Legend Biotech CorporationLEGNNASDAQ
Loading
Operating Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank86
3Y CAGR+79.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+79.2%/yr
Annual compound
Percentile
P86
Within normal range
vs 3Y Ago
5.8x
Strong expansion
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 63.38% |
| 2023 | -95.39% |
| 2022 | -1.42% |
| 2021 | 11.00% |
| 2020 | -168.47% |
| 2019 | -127.00% |
| 2018 | 13049.58% |
| 2017 | 0.00% |